Portolan Capital Management, LLC Castle Biosciences Inc Transaction History

Portolan Capital Management, LLC

$1.32 Billion
Q4 2024

A detailed history of Portolan Capital Management, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Portolan Capital Management, LLC holds 776,579 shares of CSTL stock, worth $21.2 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares

776,579

Previous 1,255,628 38.15%

Holding current value

$21.2 Million

Previous $35.8 Million 42.21%

% of portfolio

1.57%

Previous 2.85%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$26.52 - $34.67 $12.7 Million - $16.6 Million	-479,049 Reduced 38.15%	776,579 $20.7 Million
Q3 2024 Nov 14, 2024	BUY	$17.4 - $31.47 $777,362 - $1.41 Million	44,676 Added 3.69%	1,255,628 $35.8 Million
Q2 2024 Aug 14, 2024	BUY	$18.84 - $24.94 $3.16 Million - $4.18 Million	167,542 Added 16.06%	1,210,952 $26.4 Million
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $5.68 Million - $7.96 Million	314,757 Added 43.2%	1,043,410 $23.1 Million
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $5.8 Million - $10.7 Million	475,625 Added 187.97%	728,653 $15.7 Million
Q3 2023 Nov 14, 2023	SELL	$13.28 - $20.3 $2.37 Million - $3.62 Million	-178,446 Reduced 41.36%	253,028 $4.27 Million
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $2.04 Million - $4.55 Million	174,825 Added 68.12%	431,474 $5.92 Million
Q1 2023 May 15, 2023	SELL	$19.47 - $28.49 $6.37 Million - $9.32 Million	-327,067 Reduced 56.03%	256,649 $5.83 Million
Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $5.12 Million - $8.49 Million	283,126 Added 94.19%	583,716 $13.7 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $3.28 Million - $5 Million	145,622 Added 93.97%	300,590 $7.84 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $2.48 Million - $7.13 Million	154,968 New	154,968 $3.4 Million
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $548,806 - $708,255	-9,127 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $456,988 - $700,771	9,127 New	9,127 $669,000
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $976,481 - $1.61 Million	-16,573 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$43.6 - $73.05 $482,172 - $807,859	-11,059 Reduced 40.02%	16,573 $1.11 Million
Q3 2020 Nov 16, 2020	SELL	$38.47 - $52.03 $1.7 Million - $2.3 Million	-44,202 Reduced 61.53%	27,632 $1.42 Million
Q2 2020 Aug 14, 2020	SELL	$27.28 - $43.01 $1.74 Million - $2.74 Million	-63,820 Reduced 47.05%	71,834 $2.71 Million
Q1 2020 May 14, 2020	SELL	$23.08 - $35.53 $3.92 Million - $6.04 Million	-169,924 Reduced 55.61%	135,654 $4.04 Million
Q4 2019 Feb 14, 2020	BUY	$15.74 - $35.04 $2.84 Million - $6.33 Million	180,647 Added 144.6%	305,578 $10.5 Million
Q3 2019 Nov 14, 2019	BUY	$18.09 - $27.92 $2.26 Million - $3.49 Million	124,931 New	124,931 $2.26 Million

Others Institutions Holding CSTL

# of Institutions

210

Shares Held

27.3M

Call Options Held

161K

Put Options Held

38K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $718M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Account

Portolan Capital Management, LLC Castle Biosciences Inc Transaction History